CuraCell Holding AB
European biotech developing personalized T-cell therapies for solid cancer tumors.
Oversikt
- Ukjent
- Ansatte
- Ukjent
- Omsetning
- 2020
- Grunnlagt
Nøkkelbeslutningstakere
Håkan Hallberg
CFO
Lucas Arruda
Chief Scientific Officer
Thomas Schlegel
General Counsel
Jonas Båtelson
CEO
+3 flere kontakter i Funnelfeedr
Beskrivelse
CuraCell is a European biotech company focused on developing innovative T-cell therapies for the treatment of solid cancer tumors. The company utilizes its proprietary platform, CytoPLY, designed to significantly expand and activate the patient's own tumor-reactive T-cells. Their primary therapeutic...